Jan 23, 2024
Across social media and TV advertisements, drugs like Ozempic and Wegovy have risen in recent years and are quickly associated with weight loss and celebrity lifestyles. Yet semaglutide drugs (which includes Ozempic and Wegovy) are intended originally as a drug for use by adults with type 2 diabetes, to manage blood sugar levels along with diet and exercise. With the shifts towards weight loss, Ozempic has become a powerful representation of our relationships with food, and the stories of how its used and experienced by type 2 diabetics are not always at the forefront.
My guest today, Emily Wright, is here to share her personal experiences with Ozempic and the challenges she faced with severe complications from it, including gastroparesis. Emily Wright is a powerful educator, advocate, and public speaker. She is a member of two speaker’s bureaus and a regular guest lecturer at University of Toronto, Ryerson University, George Brown College, and elementary and secondary schools across the GTA. With a special ability to speak to people of all age levels, Emily uses her personal voice and story to confront stigma and create awareness across a spectrum of important social issues, including mental health and addition, homelessness, and bullying. Emily Wright has a Master’s degree in Teaching from the Ontario Institute of Studies in Education. She currently works as a curriculum consultant, speaker, and teacher for a Toronto, Ontario School Board.
Emily today uses her personal story to speak to the nuances of using Ozempic, managing type 2 diabetes, and how relationships with food and body can be profoundly impacted by Ozempic.
Learn More About Emily: